UroGen Pharma (URGN) Stock Chart & Stock Price History $11.51 +0.10 (+0.88%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$11.50 0.00 (-0.04%) As of 05/2/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UroGen Pharma Stock Price Performance 5 Day Performance+6.97%1 Month Performance+12.29%3 Month Performance+1.86%6 Month Performance-3.52%Year-To-Date Performance+8.08%1 Year Performance-19.51% Receive URGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for UroGen Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address URGN Stock Chart for Sunday, May, 4, 2025 URGN Chart by TradingView UroGen Pharma Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$11.41$11.51+0.88%$11.75$11.20484,891 shs$530.54 million05/01/2025$11.64$11.41-1.98%$11.60$11.15534,142 shs$525.93 million04/30/2025$10.76$11.64+8.18%$11.92$10.35773,012 shs$536.53 million04/29/2025$11.26$10.76-4.44%$11.43$10.71977,437 shs$495.97 million04/28/2025$9.87$11.26+14.08%$11.68$10.052.32 million shs$519.02 million04/25/2025$10.11$9.87-2.37%$10.05$9.72264,533 shs$454.95 million04/24/2025$10.20$10.11-0.88%$10.22$9.97565,680 shs$466.01 million04/23/2025$10.05$10.20+1.49%$10.51$10.081.18 million shs$470.16 million04/22/2025$9.66$10.05+4.04%$10.25$9.79378,527 shs$463.25 million04/21/2025$9.67$9.66-0.10%$10.06$9.36469,348 shs$445.27 million Get the Latest News and Ratings for URGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for UroGen Pharma and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$9.67$9.67$10.60$9.61741,549 shs$445.73 million04/17/2025$10.39$9.67-6.93%$10.60$9.61741,549 shs$478.92 million04/16/2025$10.75$10.39-3.35%$10.74$10.13274,190 shs$478.92 million04/15/2025$10.60$10.75+1.42%$10.83$10.51157,862 shs$495.51 million04/14/2025$10.12$10.60+4.74%$10.75$10.23541,114 shs$488.60 million04/11/2025$9.39$10.12+7.77%$10.14$9.21251,271 shs$466.47 million04/10/2025$10.10$9.39-7.03%$9.95$8.94888,217 shs$432.82 million04/09/2025$9.66$10.10+4.55%$10.20$8.97711,828 shs$465.55 million04/09/2025$9.66$10.10+4.55%$10.20$8.97711,828 shs$465.55 million04/08/2025$9.96$9.66-3.01%$10.49$9.53541,969 shs$445.27 million04/08/2025$9.96$9.66-3.01%$10.49$9.53541,969 shs$445.27 million04/07/2025$10.25$9.96-2.83%$10.44$9.56571,544 shs$459.10 million04/04/2025$10.53$10.25-2.66%$10.52$10.00523,746 shs$472.46 million04/03/2025$11.20$10.53-5.98%$11.19$10.30574,667 shs$485.37 million Related Companies Mirum Pharmaceuticals Stock Chart Bausch Health Companies Stock Chart Beam Therapeutics Stock Chart Gemini Therapeutics Stock Chart NewAmsterdam Pharma Stock Chart Vericel Stock Chart Belite Bio Stock Chart Tarsus Pharmaceuticals Stock Chart Janux Therapeutics Stock Chart Schrödinger Stock Chart Receive URGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for UroGen Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:URGN) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredWhy Elon put $51 million into thisWhile fear dominates the headlines, a silent breakthrough could turn panic into profit. The future of AI fa...True Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UroGen Pharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share UroGen Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy URGN Stock Free URGN Stock Alerts